Expression of the DNase encoded by the BGLF5 gene of Epstein-Barr virus in nasopharyngeal carcinoma epithelial cells

Virology

Volumn 222, Issue 1, 1996, Pages 64-74

  Sbih Lammali, Fatima ^a   Berger, Françoise ^b   Busson, Pierre ^c   Ooka, Tadamasa ^a  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; HUMAN HERPESVIRUS 4; MUS MUSCULUS; ORYCTOLAGUS CUNICULUS;

EID: 0001835862     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0398     Document Type: Article

References (45)

1. Baylis, S. A., Young, L. S., Purifoy, J. M., and Littler, E. (1991). Immunological studies on the Epstein-Barr virus encoded alkaline deoxyribonuclease found in virus-producing lymphoblastoid cells. J. Gen. Virol. 72, 399-404.
2. Boukamp, P., Petrusevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, N. E. (1988). Normal keratinization in a spontaneously immortalized aneuploid keratinocyte cell line. J. Cell Bol. 106, 761-771.
3. Bouzid, M., Belkaid, M. I., Colonna, P., Bouguermouh, A., and Ooka, T. (1993). Co-existence of the A and B Types of Epstein-Barr virus DNA in lymph node biopsies from Algerian patients with Hodgkin's disease and non-Hodgkin's lymphoma. Leukemia 7, 1451-1455.
4. Brooks, L., Yao, Q. Y., Rickinson, A. B., and Young, L. S. (1992). Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Co-expression of EBNA1, LMP1 and LMP2 transcripts. J. Virol. 66, 2689-2697.
5. Busson, P., McCoy, R., Sadler, R., Gilligan, K., Tursz, T., and Raab-Traub, N. (1992). Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J. Virol. 66, 3257-3262.
6. Busson, P., Ganem, G., Flores, P., Mugneret, F., Clausse, B., Caillou, B., Braham, K., Wakasugi, H., Lipinski, M., and Tursz, T. (1988). Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int. J. Cancer 42, 599-606.
7. Chen, J. Y., Liu, M. Y., Chen, C. J., Hsu, M. M., Tu, S. M., Lee, S. H., Kuo, S. L., and Yang, C. S. (1985). Antibody to Epstein-Barr virus specific DNase as a marker for early detection of nasopharyngeal carcinoma. J. Med. Virol. 17, 47-52.
8. Chen, J. Y., Chen, C. J., Liu, M. Y., Cho, S. M., Hsu, M. M., Lynn, T. C., Shieh, T., Tu, S. M., Lee, H. H., Kuo, S. L., Lai, M. Y., Hsieh, C. Y., Hu, C. P., and Yang, C. S. (1987). Antibodies to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control groups. J. Med. Virol. 23, 11-21.
9. Chen, H. L., Lung, M. M. L., Sham, J. S. T., Choy, D. T. K., Griffin, B. E., and Ng, M. H. (1992). Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology 191, 193-201.
10. Cheng, Y. C., Chen, J. Y., Glaser, R., and Henle, W. (1980). Frequency and levels of antibodies to Epstein-Barr virus specific DNase are elevated in patients with nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. USA 77, 6162-6165.
11. Clough, W. (1979). Deoxyribonuclease activity found in Epstein-Barr virus producing lymphoblastoid cells. Biochemistry 18, 4517-4521.
12. Clough, W. (1980). An endonuclease isolated from Epstein-Barr virus-producing human lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 77, 6194-6198.
13. Cochet, C., Martel-Renoir, D., Grunewald, V., Bosq, J., Cochet, G., Schwaab, G., Bernaudin, J. F., and Joab, I. (1993). Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 197, 358-365.
14. Decaussin, G., Leclerc, V., and Ooka, T. (1995). The lytic cycle of Epstein-Barr virus in nonproducer Raji line can be rescued by the expression of a 135 kDa protein encoded by BALF2 ORF deleted in the cells. J. Virol. 69, 7309-7314.
15. De Thé, G., Lavoué, M. F., and Muenz, L. (1987). Differences in EBV antibody titers of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. In De Thé G., Ito, Y. (eds) "Nasopharyngeal Carcinoma: Etiology and control" (G. De Thé and Y. Ito, Eds.), pp. 471-481. IARC, Lyon, France.
16. De Turenne-Tessier, M., Ooka, T., Calender, A., De Thé, G., and Daillie, J. (1989). Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus specific thymidine kinase. Int. J. Cancer 43, 45-48.
17. Fahraeus, R., Fu, H. L., Ernberg, I., Finke, J., Rowe, M., Klein, G., Falk, K., Nilsson, E., Yadav, M., Busson, P., Turz, T., and Kallin, B. (1988). Expression of Epstein-Barr Virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer 42, 329-338.
18. Gilligan, K. J., Rajadurai, P., Lin, J. C., Busson, P., Abdelhamid, M., Prasad, U., Tursz, T., and Raab-Traub, N. (1991). Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: Evidence for a viral protein expressed in vivo. J. Virol. 65, 6252-6259.
19. Hitt, M. M., Allday, M. J., Hara, T., Karran, L., Jones, M. D., Busson, P., Tursz, T., Ernberg, I., and Griffin, B. E. (1989). EBV gene expression in an NPC-related tumor. EMBO J. 8, 2639-2651.
20. Hsu, M. M., Chen, J. Y., Chen, C. J., Hsieh, T., and Lynn, T. C. (1986). Dynamics of the antibody titers to Epstein-Barr virus specific DNase and viral capsid antigen in IgA class in the course of patients with nasopharyngeal carcinoma. In Epstein-Barr Virus and Humana Diseases" (P. H. Levine, D. V. Ablashi, M. Nonoyama, G. R. Pearson, and R. Glaser, Eds.), p. 13. Humana Press, Clifton, NJ.
21. Hwang, G. Y., Li, J. K. K., Chiou, J. F., and Tan, R. S. (1980). Chromatographic purification and characterization of EBV DNase from chemically induced lymphoid cells. Virology 175, 313-318.
22. Klein, G. (1973). The Epstein-Barr virus. In "The Herpesviruses" (A. S. Kaplan, Ed.), p. 521. Academic Press, New York.
23. Lin, L. S., Ro, L. H., Lo, M. S., Huang, W. L., Ma, J., Chang, T. H., Shu, C. H., Chow, K. C., Liu, W. T., Chen, K. Y., and Yang, H. L. (1995). Expression of the Epstein-Barr virus DNA polymerase in Escherichia coli for use as antigen for the diagnosis of nasopharyngeal carcinoma. J. Med. Virol. 45, 99-105.
24. Littler, E., and Arrand, J. R. (1988). Characterization of the Epstein-Barr virus encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems. J. Virol. 62, 3892-3895.
25. Liu, M. Y., Cou, W. M., Nutter, L., Hsu, M. M., and Chen, J. Y. (1989). Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma. J. Med. Virol. 28, 101-106.
26. Luka, J., Deeb, Z. E., Hartman, D. P., Jenson, B., and Pearson, G. R. (1988). Detection of antigens associated with Epstein-Barr Virus replication in extracts from biopsy specimens of nasopharyngeal carcinomas. J. Natl. Cancer Inst. 80, 1164-1167.
27. Lung, M. L., Chan, K. H., Lam, W. P., Kou, S. K., Choy, D., Chan, C. W., and Ng, M. H. (1989). In situ detection of Epstein-Barr virus markers in nasopharyngeal carcinoma patients. Oncology 46, 310-317.
28. Middeldorp, J. M., Verhoeven, N., Benthem, E. V., and Ooka, T. (1995). "Abstract of the 20th International Herpesvirus workshop," University of Groningen, The Netherlands.
29. Ooka, T., Calander, A., de Turenne, M., and Daillie, J. (1983). Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus and relationship with a new induced thymidine kinase activity. J. Virol. 46, 187-195.
30. Ooka, T., de Turenne, M., de Thé, G., and Daillie, J. (1984). Epstein-Barr virus-specific DNase activity in nonproducer raji cells after treatment with 12-O-tetradecanoylphorbol-13-acetate and sodium butyrate. J. Virol. 49, 626-628.
31. Ooka, T., de Turenne-Tessier, M., and Stolzenberg, M. C. (1991). Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases. Springer Semin. Immunopathol. 13, 233-247.
32. Raab-Traub, N., and Flynn, K. (1986). The structure of the termini of the Epstein-Barr as a marker of clonal cellular proloferation. Cell 47, 883-889.
33. Rhim, J. S. (1989). Neoplastic transformation of human epithelial cells in vitro. Anticancer Res. 9, 1345-1366.
34. Sam, C. K., Brooks, L. A., Niedobitek, G., Young, L. S., Prasad, U., and Rickinson, A. B. (1993). Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int. J. Cancer 53, 957-962.
35. Sbih-Lammali, F., Djennaoui, D., Belaoui, H., Bouguermouh, M., Decaussin, G., and Ooka, T. (1996). Transcriptional expression of Epstein-Barr Virus genes and proto-oncogenes in North African nasopharyngeal carcinoma. J. Med. Virol. 49, 7-14.
36. Stolzenberg, M. C., and Ooka, T. (1990). Purification and properties of Epstein-Barr virus DNase expressed in Escherichia coli. J. Virol. 64, 96-104.
37. Wang, D., Liebowitz, D., and Kieff, E. (1985). An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43, 831-840.
38. Wei, M. X., and Ooka, T. (1989). A transforming function of the BAFF 1 gene encoded by Epstein-Barr virus. EMBO J. 8, 2897-2903.
39. Wei, M. X., Moulin, J. C., Decaussin, G., Berger, F., and Ooka, T. (1994). Expression of the BARF1 gene encoded by Epstein-Barr Virus in human lymphoid cells and its tumorigenicity. Cancer Res. 54, 1843-1848.
40. Williams, M. V., Boak, A., and Glaser, R. (1988). Antigenic variation in alkaline desoxyribonuclease induced by three different strains of Epstein-Barr virus. J. Med. Virol. 26, 207-215.
41. Wilson, J. B., and Levine, A. J. (1992). The oncogenic potential of Epstein-Barr nuclear antigen 1 in transgenic mice. Curr. Top. Microbiol. Immunol. 182, 375-384.
42. Wu, T. C., Mann, R. B., Epstein, J.I., MacMahon, E., Lee, W. A., Charache, P., Hayward, S. D., Kurman, R. J., Hayward, G. S., and Ambinder, R. F. (1991). Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am. J. Pathol. 138, 1461-1469.
43. Young, L. S., Dawson, C. W., Clar, D., Rupani, H., Busson, P., Turz, T., Johnson, A., and Rickinson, A. B. (1988). Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 69, 1051-1065.
44. Zhang, C. X., Decaussin, G., de Turenne, M., Daillie, J., and Ooka, T. (1987). Identification of an Epstein-Barr virus-specific desoxyribonuclease gene using complementary DNA. Nucleic Acids Res. 15, 2707-2717.
45. Zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., and Santesson, L. (1970). EBV DNA in biopsies of Burkitt tumours and anaplastic carcinoma of the nasopharynx. Nature 228, 1056-1058.